1. 1. Kim SP, Cohalan C, Kopek N, Enger SA (2019) A guide to 90Y radioembolization and its dosimetry. Phys Medica, 68: 132-145. [ DOI:10.1016/j.ejmp.2019.09.236] [ PMID] 2. Braat AJAT, Smits MLJ, Braat MNGJA, Manon NGJA, et al. (2015) 90Y Hepatic radioembolization: an update on current practice and recent developments. J Nucl Med, 56(7): 1079-87. [ DOI:10.2967/jnumed.115.157446] [ PMID] 3. Dezarn WA, Cessna JT, Dewerd LA, Feng W, et al. (2011) Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90Y microsphere brachytherapy in the treatment of hepatic malignancies. AAPM, 38(8): 4824-45. [ DOI:10.1118/1.3608909] [ PMID] 4. Cross WG, Böhm J, Charles M, Piesch E, Seltzer SM (2016) Report 56: Dosimetry of external beta rays for radiation protection. J ICRU, 29(1): 1473-6691. [ DOI:10.1093/jicru/os29.1.Report56] 5. Salem R and Thurston KG (2006) Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations. J Vasc Interv Radiol, 17(8): 1251-78.
https://doi.org/10.1097/01.RVI.0000233785.75257.9A [ DOI:10.1097/01.RVI.0000235779.88652.53] [ PMID] 6. Mitchell GS, Lloyd PNT, Cherry SR (2020) Cerenkov luminescence and PET imaging of (90)Y: capabilities and limitations in small animal applications. Phys Med Biol, 65(6): 65006-065006. [ DOI:10.1088/1361-6560/ab7502] [ PMID] [ ] 7. Jackson JD. Classical electrodynamics. American Association of Physics Teachers; 1999. 8. Krane KS. Introductory nuclear physics. John Wiley & Sons; 1991. 9. Danieli R, Milano A, Gallo S, Veronese I, Lascialfari A, et al. (2022) Personalized dosimetry in targeted radiation therapy: A look to methods, tools and critical aspects. J Pers Med, 12(2): 205. [ DOI:10.3390/jpm12020205] [ PMID] [ ] 10. Auditore L, Amato E, Italiano A, Arce P, et al. (2019) Internal dosimetry for TARE therapies by means of GAMOS Monte Carlo simulations. Phys Med Biol, 64: 245-251. [ DOI:10.1016/j.ejmp.2019.07.024] [ PMID] 11. Villalobos A, Soliman MM, Majdalany BS, Schuster DM, et al. (2020) Yttrium-90 radioembolization dosimetry: what trainees need to know. Semin Interv Radiol, 37(5): 543-554.
https://doi.org/10.1055/s-0041-1722877 [ DOI:10.1055/s-0040-1720954] [ PMID] [ ] 12. Graves SA and Hobbs RF (2021) Dosimetry for optimized, personalized radiopharmaceutical therapy. Semin Radiat Oncol, 31: 37-44. [ DOI:10.1016/j.semradonc.2020.07.008] [ PMID] 13. Cremonesi M, Chiesa C, Strigari L, Ferrari M, et al. (2014) Radioembolization of hepatic lesions from a radiobiology and dosimetric perspective. Front Oncol, 4: 210. [ DOI:10.3389/fonc.2014.00210] [ PMID] [ ] 14. Giammarile F, Bodei L, Chiesa C, Flux G, et al. (2011) EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds. EANMI, 38(7): 1393-406. [ DOI:10.1007/s00259-011-1812-2] [ PMID] 15. Goorley T, James M, Booth T, Brown F, et al. (2012) Initial MCNP6 Release Overview. Nucl Technol, 180(3): 298-315. [ DOI:10.13182/NT11-135] 16. Reed AL (2007) Medical physics calculations with MCNP: a primer. ANS Meeting, 836. 17. Jodal L (2009) Beta emitters and radiation protection. Acta Oncol, 48(2): 308-13 [ DOI:10.1080/02841860802245163] [ PMID] 18. Zankl M, Becker J, Schlattl H, Henss N, et al. (2007) Computational Phantoms of the ICRP Reference Male and Reference Female. Radiat Prot Dosim, 127(1-4): 174-86. [ DOI:10.1093/rpd/ncm269] [ PMID] 19. Synder WS, Cook MJ, Nasset ES, Karhausen LR, et al. (1974) Report on the task group on Reference Man; Pergamon Press, Oxford. 20. Abdalla EK, Denys A, Chevalier P, Nemr RA, Vauthey JN (2004) Total and segmental liver volume variations: implications for liver surgery. Surgery,135(4): 404-10. [ DOI:10.1016/j.surg.2003.08.024] [ PMID] 21. Wolf DC (1990) Evaluation of the size, shape, and consistency of the liver. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd ed. Boston: Butterworths; 1990. 22. IBM SPSS Statistics for Windows V. IBM Corp. Released Armonk, NY: IBM Corp; 2019. 23. Petitguillaume A, Bernardini M, Hadid L (2014) Three-dimensional personalized Monte Carlo dosimetry in Y-90 resin microspheres therapy of hepatic metasases: nontumoral liver and lungs radiation protection considerations and treatment planning optimization. J Nucl Med, 55 :405-413. [ DOI:10.2967/jnumed.113.120444] [ PMID] 24. Hashikin NAA, Yeong CH, Guatelli S, Abdullah BJJ, et al. (2017) Systematic investigation on the validity of partition model dosimetry for (90)Y radioembolization using Monte Carlo simulation. Phys Med Biol, 62(18): 7342-7356. [ DOI:10.1088/1361-6560/aa7e5b] [ PMID]
|